Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 5

The effect of popliteal sciatic nerve block with methylprednisolone in the management of postinjection sciatic neuropathy after clinical and electrophysiological examination

Pages
2666–2673
Publication Date
2022-11-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The EPS findings revealed a lateral truncus injury in 5, a medial truncus injury in 3, and injury to both in 9 patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: This study aimed to investigate the effects of popliteal sciatic nerve block (PSNB) in the treatment of postinjection sciatic neuropathy (PISN) resistant to conservative treatments.
📊
Key Findings & Data:Results: PSNB was performed in 17 patients (12 males and 5 females) with a diagnosis of PISN.
💡
Conclusion & Impact:The EPS findings revealed a lateral truncus injury in 5, a medial truncus injury in 3, and injury to both in 9 patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: This study aimed to investigate the effects of popliteal sciatic nerve block (PSNB) in the treatment of postinjection sciatic neuropathy (PISN) resistant to conservative treatments. Materials and methods: Patients diagnosed with PISN were included in the study. A damaged branch of the sciatic nerve was detected after neurological and electrophysiologic studies (EPSs). Visual analogue scale (VAS) was administered before, one hour after, and one month after the procedure. Also Leeds Assessment of Neuropathic Symptoms and Signs pain scale (LANSS) was administered before and one month after the procedure. The effects of EPSs findings and loss of muscle strength on the VAS and LANSS scores that measured after PSNB were evaluated. Results: PSNB was performed in 17 patients (12 males and 5 females) with a diagnosis of PISN. Their mean age was 54.95 ± 12.55 years, and the mean duration of symptoms was 3.53 ± 1.28 months. The EPS findings revealed a lateral truncus injury in 5, a medial truncus injury in 3, and injury to both in 9 patients. The initial muscle power scale scores were grade 0 in 2, grade 2 in 1, grade 3 in 7, grade 4 in 5, and grade 5 in 2 patients. The initial VAS and LANSS scores were 7.53 ± 1.06 and 17.35 ± 3.12. The mean VAS scores at the first hour and one month after the procedure decreased to 2.53 ± 1.70 and 4.18 ± 1.74 while the mean LANSS score one month after the procedure was reduced to 7.88 ± 5.84. The effects of EPSs findings and loss of muscle strength were found significant (p = 0.001), but the duration of symptoms was not found significant (p = 0.36) on the VAS and LANSS scores that measured after PSNB. Conclusion: The outcome of this research proved the effectiveness of PSNB with methylprednisolone in the management of PISN, especially in patients whose pain was located below the knee. EPSs findings and loss of muscle strength indicated the severity of the nerve damage affect the success of PSNB in pain management, but the length of time that elapsed after the nerve injury did not.Key words: Sciatic neuropathy, postinjection neuropathy, popliteal block

🔖

Cite This Article

YÜRÜK, D., TABAKOĞLU, A. Y. (2022). The effect of popliteal sciatic nerve block with methylprednisolone in the management of postinjection sciatic neuropathy after clinical and electrophysiological examination. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 5, 2666–2673. https://ajindex.com/articles/609308

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Kline DG, Hudson AR. Selected recent advances in peripheral nerve injury research. Surgical Neurology 1985
  2. 24(4):371-376. doi: 10.1016/0090-3019(85)90293-9 2. Small SP. Preventing sciatic nerve injury from intramuscular injections: literature review. Journal of Advenced Nursing 2004
  3. 47(3):287-296. doi: 10.1111/j.1365-2648.2004.03092.x 3. Kline DG, Kim D, Midha R, Harsh C, Tiel R. Management and results of sciatic nerve injuries: a 24-year experience. Journal of Neurosurgery 1998
  4. 89(1):13-23. doi: 10.3171/ jns.1998.89.1.0013 4. Clark K, Williams PE Jr, Willis W, McGavran WL. 3rd. Injection injury of the sciatic nerve. Clinical Neurosurgery 1970
  5. doi: 10.1093/neurosurgery/17.cn_suppl_1.111 5. Kline DG, Kim D, Midha R, Harsh C, Tiel R. Management and results of sciatic nerve injuries: a 24-year experience. Journal of Neurosurgery 1998
  6. 89(1):13-23. doi: 10.3171/ jns.1998.89.1.0013 6. Villarejo FJ, Pascual AM. Injection injury of the sciatic nerve (370 cases). Child’s Nervous System 1993
  7. 9(4):229-232. doi: 10.1007/BF00303575 7. Yuen EC, So YT, Olney RK. The electrophysiologic features of sciatic neuropathy in 100 patients. Muscle and Nerve 1995
  8. 18(4):414-420. doi: 10.1002/mus.880180408 8. Ramtahal J, Ramlakhan S, Singh K. Sciatic nerve injury following intramuscular injection: a case report and review of the literature. Journal of Neuroscience Nursing 2006
  9. 38(4):238-240. doi: 10.1097/01376517-200608000-00006 9. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983
  10. 17(1):45-56. doi: 10.1016/0304- 3959(83)90126-4 10. Yucel A, Senocak M, Kocasoy Orhan E, Cimen A, Ertas M. Results of the Leeds assessment of neuropathic symptoms and signs pain scale in Turkey: a validation study. Journal of Pain 2004
  11. 5(8):427-432. doi: 10.1016/j.jpain.2004.07.001 11. Geuna S, Raimondo S, Ronchi G, Di Scipio F, Tos P et al. Chapter 3: Histology of the peripheral nerve and changes occurring during nerve regeneration. International Review of Neurobiology 2009
  12. doi: 10.1016/S0074- 7742(09)87003-7 12. Grinsell D, Keating CP. Peripheral nerve reconstruction after injury: a review of clinical and experimental therapies. Biomed Research International 2014
  13. 698256. doi: 10.1155/2014/698256 13. Dubovy P, Jancalek R, Kubek T. Role of inflammation and cytokines in peripheral nerve regeneration. International Review of Neurobiology 2013
  14. doi: 10.1016/B